FCAP
First Capital, Inc.
FCAP offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has the edge over FCAP overall, supported by stronger modeled upside and lower modeled downside.
FCAP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
FCAP's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like FCAP.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
FCAP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $43.83 | -34% |
| Fair | 11x | $62.24 | -5.7% |
| Current | 12x | $66.00 | — |
| Expensive | 17x | $97.27 | +47% |
Historical ranges are pointers, not guarantees.
FCAP's PE is in its fair range at 12x.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over FCAP in the historical PE scenario, which offers more potential upside but is not a forecast.
FCAP Forward outlook
There aren't enough analyst estimates for FCAP to show an outlook.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
FCAP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $5.72 | +30% |
| Q2 2026 | $5.53 | +40% |
| Q1 2026 | $5.23 | +43% |
| Q4 2025 | $4.90 | +37% |
| Q3 2025 | $4.41 | +25% |
| Q2 2025 | $3.94 | +9.4% |
| Q1 2025 | $3.66 | +2.5% |
| Q4 2024 | $3.57 | -6.8% |
FCAP earned $5.72 per share over the past year, up 30% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
FCAP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.8M | +12% |
| Q2 2026 | $14.3M | +15% |
| Q1 2026 | $13.5M | +18% |
| Q4 2025 | $13.5M | +19% |
| Q3 2025 | $13.3M | +21% |
| Q2 2025 | $12.4M | +16% |
| Q1 2025 | $11.4M | +8.9% |
| Q4 2024 | $11.3M | +9.3% |
FCAP has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 43% | +1 points |
| Q2 2026 | 42% | +4.8 points |
| Q1 2026 | 40% | +5.6 points |
| Q3 2025 | 42% | +10 points |
| Q2 2025 | 37% | +6.2 points |
| Q1 2025 | 34% | +1.2 points |
| Q4 2024 | 35% | +0.2 points |
| Q3 2024 | 31% | -4 points |
FCAP has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
FCAP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.8M | -13% |
| Q2 2026 | $3.5M | +2.7% |
| Q1 2026 | $5.9M | +40% |
| Q4 2025 | $4.5M | +21% |
| Q3 2025 | $7.8M | +3.7% |
| Q2 2025 | $3.5M | +3.8% |
| Q1 2025 | $4.2M | -41% |
| Q4 2024 | $3.7M | +385% |
FCAP has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
FCAP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +748 shares |
| 1 year | -0.2% | -5.7K shares |
| 3 years | -0.4% | -14.6K shares |
| 5 years | -0.3% | -8.8K shares |
| Available history | -0.1% | -3.6K shares |
FCAP has 3M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $517,000 |
| Q3 2025 | $52,000 |
| Q2 2025 | — |
| Q1 2025 | $9,000 |
| Q4 2024 | — |
| Q3 2024 | $28,000 |
| Q2 2024 | $13,000 |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over FCAP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
FCAP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
| Q2 2024 | -1.5x | Net Cash |
| Q1 2024 | -1.3x | Net Cash |
| Q4 2023 | -1.2x | Net Cash |
FCAP has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FCAP.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
FCAP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.3 | Neutral |
| Stochastic | 64.3 | Neutral |
FCAP's weekly RSI is 60 (neutral) and its Stochastic is 64 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
FCAP PE vs Financial Services Sector
| Metric | FCAP | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 11% below |
| PE % | 58 | 63 | 5 pts below |
FCAP has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
FCAP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.7 | 5.3% above |
| 20 week MA | $62.8 | 5.1% above |
| 50 week MA | $58.6 | 13% above |
| 100 week MA | $49.6 | 33% above |
| 200 week MA | $39.5 | 67% above |
FCAP has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
FCAP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $68.5 | $63.1 | -7.9% |
| 2021 | $63.1 | $40.5 | -36% |
| 2022 | $40.5 | $24.4 | -40% |
| 2023 | $24.4 | $27.9 | +14% |
| 2024 | $27.9 | $32.3 | +16% |
| 2025 | $32.3 | $59.9 | +86% |
| 2026 YTD | $59.9 | $66.0 | +10% |
FCAP has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.